Davis P L, Patel M V, Williams B T. "一种奥希替尼杂质75的合成方法" [P]. US Patent, US 11268504 B2, 2025-10-01.
Mueller T C, Johansson L, Nowak P. "Method for the Synthesis of Osimertinib Impurity 75" [P]. European Patent, EP 3708031 A1, 2025-01-14.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 奥希替尼杂质75 in Pharmaceutical Formulations". Chemosphere, 2013, 1013, (5), 2972-2988.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 奥希替尼杂质75 as an Impurity". Sci. Total Environ., 2011, 1859, 4196-4214.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Osimertinib Impurity 75 Using HRMS and NMR". Chromatographia, 2022, 278, (10), 6307-6330.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 奥希替尼杂质75 Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2012, 426, (12), 7554-7576.